BLY had a price earning at 6x and EBITDA at 3x as at 2 months ago.If you bought 10 years ago and not reassessed the position and held then you would have lost 100% plus opportunity cost of about 10%p.a -
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status